Status
Conditions
Treatments
About
as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of the patients could not acheive viral clearence with the standard module of care teh idea of introduction of new medications in the treatment protocol of COVID 19 managment. Ivermectin had shown a promising results in vitro studies and in limited in vivo studies. this clinical trial may open a new hope for COVID 19 patients as a new and cheap line of treatment
Full description
the study will compare the effect of ivermectin in comaprison and addition to the standard mode of care for the COVID 19 patients
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
100 participants in 3 patient groups
Loading...
Central trial contact
ehab ah kamal, MD; noha mo asem, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal